StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Bismut hydroxid nitrat oxid

Bismuth Subnitrate

HCID 73415757
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
1304-85-4
Standard-SMILES
O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[O-2].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-]
InChIKey
QGWDKKHSDXWPET-UHFFFAOYSA-E
Summenformel
Bi5H9N4O22
Durchschnittliche Molmasse
1.461,99 g/mol
Monoisotopische Masse
1.461,87284

Überblick

Bismuth subnitrate, also referred to as bismuth oxynitrate or bismuthyl nitrate, is a highly water-soluble crystalline compound that has been used as a treatment for duodenal ulcers and anti-diarrheic agent. The use of bismuth substrate as an active ingredient in over-the-counter antacids is approved by the FDA.

Namen und Bezeichner

Bevorzugter Name
Bismuth Subnitrate
IUPAC
pentabismuth;oxygen(2-);nonahydroxide;tetranitrate
Lokaler Name
Bismut hydroxid nitrat oxid
Englischer Name
Bismuth subnitrate
Summenformel
Bi5H9N4O22
Molmasse
1461.99

Namen und Synonyme

Bismuth nitrate, basicBasic bismuth nitrateNovismuthVicalinVikalineBismuth paintBismuth SynlabBismuth WhiteCosmetic WhiteSpanish WhiteFlake WhitePaint White
Weitere Namen anzeigen
BISMUTH OXYNITRATEc.i.77169flakewhitepaintwhitesnowcal5swblancdefardbismuthpaint
Blanc de fardBismuth magisteryBismuthyl nitrateBismuth subnitricumSnowcal 5SWSnowcal 5 SWBismuthum subnitricumMagistery of bismuth

Datenbank-Bezeichner

CAS
1304-85-4、54392-33-5
PubChem CID
73415757
DTXSID
DTXSID40893872
ChEMBL
CHEMBL3833348
UNII
H19J064BA5
EC Number
215-136-8、611-133-4

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
262 Ų
H-Brücken-Donoren
9
H-Brücken-Akzeptoren
22
Frei drehbare Bindungen
0
Schwere Atome
31
Formalladung
0
Komplexität
18,8

Experimentelle und physikochemische Eigenschaften

Chemical ClassesMetals -> Metals, Inorganic Compounds
CosmeticsOpacifying; Absorbent
pHSHOWS ACID TO MOISTENED LITMUS PAPER
OdorODORLESS
TasteTASTELESS
Density4.928
Color/Form · 2 Einträge

HEAVY, MICROCRYSTALLINE POWDER

WHITE POWDER

Solubility · 3 Einträge

Insoluble

PRACTICALLY INSOL IN WATER, ALC; SOL IN DILUTE HYDROCHLORIC ACID & NITRIC ACID

PRACTICALLY INSOL IN ORGANIC SOLVENTS

Animal DrugsPharmaceuticals -> UK Veterinary Medicines Directorate List
Boiling Point · 2 Einträge

Decomposes at 260

BOILING POINT: 260 °C -HNO3 /BIONO3.H2O/

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 6 Einträge

This chemical does not meet GHS hazard criteria for 58.1% (115 of 198) of all reports.

Danger

H272 (24.2%): May intensify fire; oxidizer [Danger Oxidizing liquids; Oxidizing solids]

P210, P220, P260, P261, P264, P264+P265, P270, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P370+P378, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 198 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

Gefahrenhinweise

Regulatory Information · 4 Einträge

Chemical: Bismuth hydroxide nitrate oxide, (Bi5(OH)9(NO3)4O)

Bismuth hydroxide nitrate oxide (Bi5(OH)9(NO3)4O) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Bismuth hydroxide nitrate oxide (Bi5(OH)9(NO3)4O) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

REACH registered substance: Bismuth hydroxide nitrate oxide (EC: 215-136-8)

Bismuth hydroxide nitrate oxide: HSNO Approval: HSR001433 Approved with controls

Fire PotentialHAZARD: OXIDIZING MATERIAL; FIRE RISK NEAR ORGANIC MATERIALS.
Hazards SummaryAn irritant; Oxidizing agent--keep away from combustible materials; [MSDSonline] See Bismuth. See NITRATES and NITRITES.
Hazard Classes and Categories · 2 Einträge

Ox. Sol. 2 (24.2%)

Specific target organ toxicity - Single exposure - Category 2 (central nervous system, blood)

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

A - Alimentary tract and metabolism

QA - Alimentary tract and metabolism

Protein BindingUpon accumulation in the kidneys, bismuth may bind to a bismuth-metal binding protein in the kidney.
Pharmacodynamics · 1 Eintrag

Bismuth subnitrate acts as an antacid that exert protective effects on the gastric mucosa. In a double-blind endoscopically controlled study, bismuth substrate was demonstrated to be effective for symptomatic relief in duodenal ulcers. In the alcohol model of mucosal injury in the rat, bismuth substrate was shown to be cytoprotective. In a randomized clinical study consisting of patients with _H. pylori_-associated duodenal ulcer, adjunctive use of colloidal bismuth subnitrate in a short treatment regimen with omeprazole and clarithromycin resulted in improved eradication rate of _H. pylori_.

Mechanism of Action · 1 Eintrag

Based on the findings of a clinical investigation in patients with duodenal ulcer disease and healthy volunteers receiving oral bismuth subnitrate tablets, the protective effects of bismuth subnitrate may be secondary to endogenous mucosal prostaglandin (PGE2) production, which is one of the deficient factors observed in peptic ulcer disease. Antacid neutralizing activity of bismuth subnitrate was demonstrated to have a significant postprandial effect on gastric pH.

Biological Half-LifeThe distribution half-life of bismuth is approximately 1 to 4 hours, and the elimination half-life is 5 to 11 days.
Metabolism/MetabolitesNo pharmacokinetic data available.
FDA Pharmacological Classification · 4 Einträge

BISMUTHUM SUBNITRICUM

Bismuth [CS]; Bismuth [EPC]

BISMUTH SUBNITRATE

Bismuth [CS]; Bismuth [EPC]

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Decomposition
Decomposes to Bi2O3 and nitrogen oxides when heated to red heat.
Melting Point · 2 Einträge

Decomposes at 260

260 °C DECOMP

Physikochemische Eigenschaften

Schmelzpunkt
260 °C · 260°C
Dichte
4.928 · 4.928
Dampfdruck
0 Pa · 0Pa at 20℃
storage temp.
5 °C · Store at +5°C to +30°C.
Löslichkeit
Practically insoluble in water and in ethanol (96 per cent). It dissolves in mineral acids with decomposition.
Aggregatzustand
Powder/Solid
Farbe
White
PH
3.2 · 3.2 (50g/l, H2O, 20℃)(slurry)
Wasserlöslichkeit
3 · Practically insoluble in water and alcohol. Soluble in dilute HNO{3} and HCl
Merck
14 · 14,1284
Stabilität
Stability Strong oxidizer - contact with combustible material may lead to fire. Incompatible with reducing agents, organic materials.
Major Application
pharmaceutical (small molecule)
Kosmetik-Inhaltsstoffe Funktionen
OPACIFYINGABSORBENT
InChI
1S/5Bi.4NO3.9H2O.O/c;;;;;4*2-1(3)4;;;;;;;;;;/h;;;;;;;;;9*1H2;/q+1;4*+3;4*-1;;;;;;;;;;/p-9
InChIKey
OAVDTZZNYFIIGB-UHFFFAOYSA-E
SMILES
O[Bi]=O.O[Bi](O)O[N+]([O-])=O.O[Bi](O)O[N+]([O-])=O.O[Bi](O)O[N+]([O-])=O.O[Bi](O)O[N+]([O-])=O
CAS Datenbank
1304 · 1304-85-4(CAS DataBase Reference)
EPA chemische Informationen
Bismuth hydroxide nitrate oxide (Bi5(OH)9(NO3)4O) (1304-85-4)
Hazardous Reactivities and IncompatibilitiesIncompatible with alkaline bicarbonates, soluble iodides, gallic acid, calomel, salicylic acid, tannin, and sulfur.

Sicherheit und Schutzausrüstung

Storage Conditions · 2 Einträge

...MATERIALS WHICH ARE TOXIC AS STORED OR WHICH CAN DECOMPOSE INTO TOXIC COMPONENTS...SHOULD BE STORED IN A COOL, WELL-VENTILATED PLACE, OUT OF THE DIRECT RAYS OF THE SUN, AWAY FROM...FIRE HAZARD...PERIODICALLY INSPECTED & MONITORED. /NITRATES/

Keep well closed and protect from light.

Toxikologische Informationen

InteractionsThe gastrointestinal absorption of bismuth subnitrate has been reported ... to be increased by concomitant administration of sulfhydryl compounds.
Adverse EffectsMethemoglobinemia - The presence of increased methemoglobin in the blood; the compound is classified as secondary toxic effect
Human Toxicity Excerpts · 4 Einträge

ESPECIALLY IN INFANTS, THE SUBNITRATE MAY BE REDUCED BY BACTERIA WITHIN THE BOWEL, TO YIELD NITRITE, WHICH CAUSES METHEMOGLOBINEMIA AFTER ABSORPTION.

A PT POISONED BY TAKING 8 G OF BISMUTH SUBNITRATE TEMPORARILY HAD FOGGY VISION ON 2ND DAY OF POISONING.

CLIN SYMPTOMS AND LAB EXAM FINDINGS OF CASE OF POISONING (CENTRAL NERVOUS SYSTEM SYNDROME) AFTER A LONG-TERM INTAKE OF BI SUBNITRICUM (3 G/DAY, 2-3 WK) ARE REPORTED. DISCONTINUATION OF DRUG COMPLETELY IMPROVED CLIN SYMPTOMS.

ORAL ADMIN...PRODUCES POISONING THROUGH THE FORMATION OF NITRITES.

Non-Human Toxicity Excerpts · 5 Einträge

FOLLOWING SC INJECTIONS (5 G OF BISMUTH SUBNITRATE EACH DAY FOR 3 DAYS), DEGENERATIVE CHANGES & INTRANUCLEAR & INTRACYTOPLASMIC INCLUSIONS APPEARED IN RENAL PROXIMAL TUBULES OF RABBITS.

.../TREATMENT/ OF DOGS BY DAILY SC INJECTION OF BISMUTH SUBNITRATE...INDUCED IRRITATION OF EYES & LACRIMATION & RESULTED IN DEVELOPMENT OF WHITE OPACITIES IN UPPER 2/3 OF CORNEAS.

MICRONIZED HEAVY BISMUTH SUBNITRATE FED TO 99 FEMALE SPF RATS 60-70 DAYS (BI 5 G/KG/DAY), WITH 69 RATS AS CONTROLS. TEST ANIMALS BODY WT MUCH LOWER. DIFFERENCES IN LIVER & KIDNEY WT OF 2 GROUPS. TEST ANIMALS BI BLOOD & CEREBRAL LEVELS 200 & 5 TIMES HIGHER, RESPECTIVELY.

IN MICE, BI SUBNITRATE (0.4 ML/20 G OF STD SOLN, IV) WAS LETHAL WHEN DISSOLVED IN WATER, BUT NOT WHEN IN NACL SOLN. MICE ADMIN 500 MG/KG ORALLY HAD SOFTER STOOLS, AS COMPARED TO CONTROLS, AND FACIAL EDEMA.

For more Non-Human Toxicity Excerpts (Complete) data for BISMUTH SUBNITRATE (6 total), please visit the HSDB record page.

Sicherheitsdaten

F
8
wgk
3
tsca
TSCA listed
ridadr
UN 1477 5.1/PG 2
hs_code
2834299090
RTECS-Nr.
EB2977000
risk_code
8-36/37/38
Toxizität
infant,LDLo,oral,1gm/kg (1000mg/kg),"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 134, 1969.
hazard_code
O,Xi
safety_code
17-26-36/37/39-36
hazard_class
5.1
packing_group
II
Speicherklasse
13 - Non Combustible Solids
Giftige Stoffe Daten
1304-85-4(Hazardous Substances Data)
MeSH Pharmacological Classification
Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT.
Absorption, Distribution and Excretion · 5 Einträge

Bismuth subnitrate may undergo minimal gastrointestinal absorption which may be potentiated with concomitant administration of sulfhydryl compounds when dissolved in citrate buffer solution. Approximately 0.2% of orally administered bismuth is absorbed systematically from the gastrointestinal tract with the peak plasma concentration typically occurring within 1 hour.

Bismuth may undergo both urinary and faecal excretion, however the exact proportion contributed by each route is still unknown.

Bismuth has been shown to accumulate preferentially in the kidneys.

No pharmacokinetic data available.

WITH DAILY ORAL ADMIN OF 0.5 G/KG BISMUTH SUBNITRATE, BLOOD BI LEVELS WERE GREATER WITH HEAVY MICRONIZED (665 UG/L) THAN WITH ORDINARY HEAVY BI SUBNITRATE (85 UG/L). KIDNEY BI LEVELS WERE 17 TIMES GREATER THAN LIVER LEVELS WHILE LITTLE BI PASSED INTO THE BRAIN.

Verwendung und Herstellung

Uses · 5 Einträge

Used to make enamel fluxes, cosmetics, antacids, and antiulceratives; [Merck Index] Used as an astringent, adsorbent, and protective; in topical lotions and ointments; [HSDB]

Enameling [Category: Hobbies]

IN PREPN OF MILK OF BISMUTH, AS ASTRINGENT, ADSORBENT, & PROTECTANT

COATING AGENT IN PREPARATIONS FOR GASTRITIS; IN BLEACHING CREAMS

Medication

U.S. Imports(1972) 2.83X10+6 GRAMS
U.S. Production2023: 1,000,000 - <8,500,000 lb
Industry UsesCatalyst
Methods of ManufacturingPREPARED BY PARTIAL HYDROLYSIS OF BI(NO3)3
Formulations/Preparations · 2 Einträge

GRADES: TECHNICAL; CP; NF.

VET: /9% BISMUTH SUBNITRATE FORMULATION/... FOR TREATMENT OF SKIN CONDITIONS SUCH AS MINOR WOUNDS, ABRASIONS, ECZEMAS & INFLAMMATION OF EXTERNAL EAR CANAL.

Use ClassificationCosmetics -> Opacifying; Absorbent
General Manufacturing Information · 4 Einträge

Paint and Coating Manufacturing

Bismuth hydroxide nitrate oxide (Bi5(OH)9(NO3)4O): ACTIVE

INCOMPATIBILITIES: ALKALINE BICARBONATES, SOLUBLE IODIDES, GALLIC ACID, CALOMEL, SALICYLIC ACID, TANNIN, SULFUR.

(VET): HAS BEEN USED EXTERNALLY IN DUSTING POWDERS FOR INDOLENT, MOIST OR SUPPURATING LESIONS, & AS AN X-RAY CONTRAST MEDIUM.

Anwendungen · 2 Einträge

BeschreibungBismuth subnitrate, also referred to as bismuth oxynitrate or bismuthyl nitrate, is a highly water-soluble crystalline compound that has been used as a treatment for duodenal ulcers and anti-diarrheic agent. The use of bismuth substrate as an active ingredient in over-the-counter antacids is approved by the FDA. Bismuth Subnitrate is a basic salt that contains the equivalent of not less than 79.0 percent of bismuth trioxide (Bi2O3),calculated on the dried basis.It is both odorless and tasteless, and is used in bleaching and freckle creams, and hair dyes. Bismuth subnitrate has been used to induce metallothionein in heart tissue and kidneys and to attenuate the toxicity of Adriamycin and cisplatin compounds, respectively.

VerwendenBismuth subnitrate (BiNO3) is used in the cosmetics industry and to make ceramic and enamel glazes.